124 related articles for article (PubMed ID: 14967457)
1. Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studies.
Milas L; Fan Z; Andratschke NH; Ang KK
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):966-71. PubMed ID: 14967457
[TBL] [Abstract][Full Text] [Related]
2. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis.
Huang SM; Harari PM
Clin Cancer Res; 2000 Jun; 6(6):2166-74. PubMed ID: 10873065
[TBL] [Abstract][Full Text] [Related]
3. In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.
Milas L; Mason K; Hunter N; Petersen S; Yamakawa M; Ang K; Mendelsohn J; Fan Z
Clin Cancer Res; 2000 Feb; 6(2):701-8. PubMed ID: 10690556
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide.
Bianco C; Bianco R; Tortora G; Damiano V; Guerrieri P; Montemaggi P; Mendelsohn J; De Placido S; Bianco AR; Ciardiello F
Clin Cancer Res; 2000 Nov; 6(11):4343-50. PubMed ID: 11106252
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225.
Ciardiello F; Bianco R; Damiano V; De Lorenzo S; Pepe S; De Placido S; Fan Z; Mendelsohn J; Bianco AR; Tortora G
Clin Cancer Res; 1999 Apr; 5(4):909-16. PubMed ID: 10213228
[TBL] [Abstract][Full Text] [Related]
6. C225 antiepidermal growth factor receptor antibody enhances the efficacy of docetaxel chemoradiotherapy.
Nakata E; Hunter N; Mason K; Fan Z; Ang KK; Milas L
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1163-73. PubMed ID: 15234052
[TBL] [Abstract][Full Text] [Related]
7. Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis.
Viloria-Petit A; Crombet T; Jothy S; Hicklin D; Bohlen P; Schlaeppi JM; Rak J; Kerbel RS
Cancer Res; 2001 Jul; 61(13):5090-101. PubMed ID: 11431346
[TBL] [Abstract][Full Text] [Related]
8. Enhanced response to C225 of A431 tumor xenografts growing in irradiated tumor bed.
Riesterer O; Mason KA; Raju U; Yang Q; Wang L; Hittelman WN; Ang KK; Milas L
Radiother Oncol; 2009 Sep; 92(3):383-7. PubMed ID: 19695723
[TBL] [Abstract][Full Text] [Related]
9. Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation.
Harari PM; Huang SM
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):427-33. PubMed ID: 11173137
[TBL] [Abstract][Full Text] [Related]
10. Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas.
Akimoto T; Hunter NR; Buchmiller L; Mason K; Ang KK; Milas L
Clin Cancer Res; 1999 Oct; 5(10):2884-90. PubMed ID: 10537357
[TBL] [Abstract][Full Text] [Related]
11. Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.
Prewett M; Rothman M; Waksal H; Feldman M; Bander NH; Hicklin DJ
Clin Cancer Res; 1998 Dec; 4(12):2957-66. PubMed ID: 9865906
[TBL] [Abstract][Full Text] [Related]
12. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
Sok JC; Coppelli FM; Thomas SM; Lango MN; Xi S; Hunt JL; Freilino ML; Graner MW; Wikstrand CJ; Bigner DD; Gooding WE; Furnari FB; Grandis JR
Clin Cancer Res; 2006 Sep; 12(17):5064-73. PubMed ID: 16951222
[TBL] [Abstract][Full Text] [Related]
13. Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model.
Goldstein NI; Prewett M; Zuklys K; Rockwell P; Mendelsohn J
Clin Cancer Res; 1995 Nov; 1(11):1311-8. PubMed ID: 9815926
[TBL] [Abstract][Full Text] [Related]
14. Anti-EGFR-mediated radiosensitization as a result of augmented EGFR expression.
Bonner JA; Buchsbaum DJ; Russo SM; Fiveash JB; Trummell HQ; Curiel DT; Raisch KP
Int J Radiat Oncol Biol Phys; 2004; 59(2 Suppl):2-10. PubMed ID: 15142629
[TBL] [Abstract][Full Text] [Related]
15. Significance of interleukin-6 signaling in the resistance of pharyngeal cancer to irradiation and the epidermal growth factor receptor inhibitor.
Chen CC; Chen WC; Lu CH; Wang WH; Lin PY; Lee KD; Chen MF
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1214-24. PubMed ID: 20206020
[TBL] [Abstract][Full Text] [Related]
16. Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation.
Milas L; Fang FM; Mason KA; Valdecanas D; Hunter N; Koto M; Ang KK
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):568-72. PubMed ID: 17236972
[TBL] [Abstract][Full Text] [Related]
17. Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiation.
Saleh MN; Raisch KP; Stackhouse MA; Grizzle WE; Bonner JA; Mayo MS; Kim HG; Meredith RF; Wheeler RH; Buchsbaum DJ
Cancer Biother Radiopharm; 1999 Dec; 14(6):451-63. PubMed ID: 10850332
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor (EGFR) antibody-induced antibody-dependent cellular cytotoxicity plays a prominent role in inhibiting tumorigenesis, even of tumor cells insensitive to EGFR signaling inhibition.
Overdijk MB; Verploegen S; van den Brakel JH; Lammerts van Bueren JJ; Vink T; van de Winkel JG; Parren PW; Bleeker WK
J Immunol; 2011 Sep; 187(6):3383-90. PubMed ID: 21832160
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapies for non-small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective.
Raben D; Helfrich B; Bunn PA
Int J Radiat Oncol Biol Phys; 2004; 59(2 Suppl):27-38. PubMed ID: 15142632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
